Depression and Anxiety Trial, Recruiting NCT07009028 Sponsor: Ege University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07009028
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child must be willing to take part in the study
  • The child must be between 6 and 9 years old
  • This must be the first time the child is having a needle placed in their vein (IV line) since arriving at the clinic
  • The child must not have any problems with their vision, hearing, or speech
  • The child must not have any intellectual or learning disabilities
  • The child and/or family must be able to speak and understand Turkish
  • The child must not be experiencing pain, nausea, or vomiting at the time of the study, as these could affect feelings of fear or anxiety
  • The child must not have been given any calming or pain-relieving medication just before the IV needle is inserted

Who may not be able to join:

  • The child has a long-term, inherited, metabolic, or nervous system condition
  • The first attempt to place the IV needle was unsuccessful
  • The child or family is unable to fully complete the study questionnaires
  • The child had another procedure involving needles or similar interventions just before the IV needle was inserted
  • The child is not cooperative or does not follow instructions during the procedure
  • The child wishes to stop taking part in the study at any point

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ayşe Kahraman, Assoc Prof, Ege Universty

Phone: +905358700970

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ege University
Registry
ClinicalTrials.gov
Start date
20 May 2025
Est. completion
20 August 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Reducing the child's fear; Reducing the child's anxiety; Reducing the child's pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov